Today: 29 April 2026
Bitcoin Slides to 15-Month Low Near $72,000 as Crypto Rout Wipes Almost $500 Billion
4 February 2026
2 mins read

Bitcoin Slides to 15-Month Low Near $72,000 as Crypto Rout Wipes Almost $500 Billion

NEW YORK, Feb 4, 2026, 14:26 EST

  • Bitcoin dropped up to 5.4%, hitting $72,047—its lowest level since November 2024
  • CoinGecko data showed the total crypto market value has dropped roughly $467.6 billion since Jan. 29
  • Recent days saw $2.56 billion worth of bitcoin positions liquidated, according to CoinGlass data

Bitcoin dropped up to 5.4%, sliding to $72,047 on Wednesday—the weakest since roughly 15 months ago—amid a wider selloff in cryptocurrencies. The Nasdaq 100 also dipped over 2%, dragged down by rate-sensitive shares.

The decline unfolds amid a broad pullback from risk assets, with global equities falling and the dollar gaining ground as traders grapple with U.S. interest rate prospects and ongoing geopolitical concerns. Oil prices rose, driven by sustained tensions between the U.S. and Iran.

Bitcoin’s “digital gold” narrative is facing fresh skepticism after it struggled to maintain steady demand in a week when investors sought safe havens. “Asia morning sentiment is cautious and defensive,” said BTC Markets analyst Rachael Lucas, noting that dips below $73,000 have driven sentiment into “extreme fear.” The Economic Times

A surge of forced selling has intensified price swings. According to CoinGlass, $2.56 billion in bitcoin positions were liquidated over the past few days — liquidations occur when leveraged bets are automatically closed as losses exceed the collateral posted. Kaiko analyst Adam McCarthy said investors are “taking a step back” to reassess risk. Meanwhile, Charles Schwab’s Jim Ferraioli highlighted external shocks, including a blow to the so-called AI trade — bets linked to artificial intelligence stocks. Reuters

Derivatives markets are showing warning signs. Open interest—the number of outstanding futures contracts—dropped sharply over the weekend. At the same time, funding rates on perpetual futures turned negative, indicating traders are shifting toward bearish bets. “Crypto sentiment is hitting rock bottom,” said Augustine Fan, partner at options platform SignalPlus. The National

Losses widened among key tokens as the selloff intensified. Ether and Solana both took steep hits in the past 24 hours, while liquidations across the broader market surpassed $650 million, according to Decrypt.

Crypto-related stocks are slipping alongside bitcoin, with investors using them to gauge its moves. Coinbase and bitcoin-treasury company Strategy have both dropped by at least 15% in the past five trading days, according to Investopedia.

U.S. stocks slid further, weighed down by skepticism around software firms. Investors flagged fresh AI developments as a fresh risk to profit margins and pricing strength.

The bigger concern is what unfolds if the sell-off persists and major holders start feeling trapped. Business Insider highlighted $76,000 — the average purchase price for bitcoin held by Strategy — as a critical level traders have their eyes on. Meanwhile, Zacks Investment Research chief strategist John Blank warned that bitcoin could drop as low as $40,000.

Policy uncertainty is adding pressure. A White House meeting meant to resolve deadlock between banks and crypto companies over stablecoin rewards — these tokens are usually tied to the dollar — wrapped up with no deal. That leaves a key U.S. market-structure bill stalled.

Traders are keeping an eye on whether the liquidation pressure will ease and if the stock selloff will stabilize. Crypto markets never sleep, and the next shock often hits when liquidity is at its lowest.

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Cambridge, Massachusetts, April 29, 2026, 09:04 EDT Biogen Inc. cut its full-year profit outlook on Wednesday, taking some shine off a first-quarter earnings beat driven by stronger sales of its Alzheimer’s drug Leqembi and newer rare-disease medicines. The Cambridge, Massachusetts-based drugmaker now expects 2026 adjusted earnings of $14.25 to $15.25 a share, down $1 at both ends of its prior range. Biogen said the cut reflects acquired in-process research and development charges, meaning costs tied to buying or licensing drug programs that are still being developed and have not yet become commercial products. The revision matters because Biogen is trying
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Dow Jones slips while Nasdaq slides as tech selloff bites again
Previous Story

Dow Jones slips while Nasdaq slides as tech selloff bites again

Fortive stock jumps on upbeat 2026 profit view after Q4 beat, buybacks
Next Story

Fortive stock jumps on upbeat 2026 profit view after Q4 beat, buybacks

Go toTop